Stephanie Washburn has nearly twenty years in medical device Clinical and Medical Affairs across Class I through III programs. She works as Principal Consultant and leads the team.
At Abbott (formerly St. Jude Medical Neuromodulation) she worked on spinal cord and peripheral nerve stimulation: post-market studies, IDE and post-approval work, 510(k) and CE support, and peer-reviewed papers in Neuromodulation, Cephalalgia, and the Clinical Journal of Pain. Roles included clinical monitoring, data analysis, project management, and medical writing.
As VP, Clinical and Medical Affairs at Spark Biomedical, she built the clinical function and managed the in-house study for opioid withdrawal, from Pre-Sub through FDA clearance.
She was an MSL for electroCore / gammaCore, supporting nVNS for migraine and cluster headache — field medical work for a commercial neuromodulation therapy, including scientific exchange with treating clinicians.
She was Head of Clinical and Medical Affairs Strategy at an early-stage SaMD start-up, building the clinical and evidence infrastructure the company needed before it had a Clinical and Medical Affairs department.